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Introduction
Colorectal cancer is considered as one of the major 
causes of morbidity and mortality in the world. This 
disease accounts for 9.7% of all cancer deaths, and is the 
most commonly diagnosed cancer after lung and female 
breast cancer (Ferlay et al., 2010). In Malaysia, colorectal 
cancer is the second most frequent type of cancer with 
high prevalence in male than to female population (Omar 
et al., 2006).
Contemporary therapeutic methods for this type 
of cancer have been primarily on surgical measures 
and chemotherapy (Mayer, 2009). However, despite 
remarkable progress in these approaches, effective 
therapeutic outcome is minimal owing to the incomplete 
eradication of the disease and unfavorable side effects, 
which regularly impede effective treatment (Braun and 
Seymour, 2011). 5-Fluorouracil (5-FU) is one of the most 
commonly used therapeutic agents in first-line therapy 
against colorectal cancer. The drug exerts its anti-cancer 
effects by inhibiting the activity of thymydilate synthase 
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Abstract
 The development of chemopreventive approaches using a concoction of phytochemicals is potentially viable 
for combating many types of cancer including colon carcinogenesis. This study evaluated the anti-proliferative 
effects of ginger and Gelam honey and its efficacy in enhancing the anti-cancer effects of 5-FU (5-fluorouracil) 
against a colorectal cancer cell line, HCT 116. Cell viability was measured via MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphenyl)-2H-tetrazolium) assay showing ginger inhibiting the growth 
of HCT 116 cells more potently (IC50 of 3mg/mL) in comparison to Gelam honey (IC50 of 75mg/mL). Combined 
treatment of the two compounds (3mg/mL ginger+75mg/mL Gelam honey) synergistically lowered the IC50 of 
Gelam honey to 22mg/mL. Combination with 35 mg/mL Gelam honey markedly enhanced 5-FU inhibiting 
effects on the growth of HCT 116 cells. Subsequent analysis on the induction of cellular apoptosis suggested 
that individual treatment of ginger and Gelam honey produced higher apoptosis than 5-FU alone. In addition, 
treatment with the combination of two natural compounds increased the apoptotic rate of HCT 116 cells dose-
dependently while treatment of either ginger or Gelam honey combined with 5-FU only showed modest changes. 
Combination index analysis showed the combination effect of both natural compounds to be synergistic in their 
inhibitory action against HCT 116 colon cancer cells (CI 0.96 < 1). In conclusion, combined treatment of Gelam 
honey and ginger extract could potentially enhance the chemotherapeutic effect of 5-FU against colorectal cancer. 
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(TS) and disrupting DNA & RNA synthesis (Longley 
et al., 2003) While its survival benefit has been firmly 
established, clinical applications of the drug have been 
greatly restricted due to the acquired drug resistance as 
well as toxicity in higher dosage (Meregalli et al., 1998). 
In this sense, new strategies involving several anti-tumor 
modulators have been applied in combination of this drug 
to boost its efficacy while conserving acceptable toxicities. 
The beneficial effect of combined drug treatment such 
as the anti-cancer drugs Oxaliplatin +5-FU or Irinotecan 
+5-FU was observed to increase patient’s survival rate 
thus expanding the median survival period (Douillard et 
al., 2000; Giacchetti et al., 2000). 
The concept of dual therapy of anti-cancer drugs 
with natural compounds has become a very promising 
approach in new drug discovery. Phytochemicals from 
natural resources, readily available in our daily diet are 
now being utilized for chemoprevention (Rajamanickam 
and Aggarwal, 2008). Thus, the new concept of combined 
chemoprevention by multiple agents or by the consumption 
of “whole foods” has become an increasingly attractive 
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area of study (Mehta et al., 2010). Several reports have 
described the ability of these naturally derived compounds 
to modulate the process of carcinogenesis; either by 
blocking or reversing, with nominal cytotoxicity (Braun 
and Seymour, 2011; Lee et al., 2011). For example the 
use of natural compounds in combination with 5-FU may 
provide effective colorectal cancer treatment by enhancing 
tumoricidal activity while reducing dose-related toxicity 
and resistance. 
Ginger (Zingiber officinale) is one of many dietary 
substances that are rich in phytochemicals. For centuries, 
it has been used as food flavoring agent as well as for 
traditional medicinal purposes (Ali et al., 2008). Current 
trend in research has focused its attention to ginger given its 
anti-cancer, anti-oxidant, and anti-inflammatory properties 
(Masuda et al., 2004; Grzanna et al., 2005; Shukla and 
Singh, 2007; Habib et al., 2008). Recently, our laboratory 
has demonstrated anti-tumor effects of ginger extracts 
against colon cancer cell lines through the induction of 
apoptotic pathway coupled with cell cycle arrest at G0/G1 
phase (Abdullah et al., 2010). Ginger extracts is known 
to contain numerous potent phytochemicals including 
gingerols, shogaols, zingerols, and paradols (Jolad et 
al., 2004). Of these phenolic constituents, shogaols 
and gingerols are the principal active pharmacological 
components of ginger. They exhibited growth-inhibitory 
effects against other cancer cells namely lung, ovarian, 
and skin cells (Kim et al., 2008). 
Honey is a natural product of bees, rich in phenolic 
compounds and other essential vitamins and enzymes 
(Cherchi et al., 1994; Havsteen, 2002; Jaganathan and 
Mandal, 2009). Studies have indicated the range of health 
benefits of honey, which includes anti-inflammatory, 
antioxidant and wound healing activities (Kassim et al., 
2010; Mohamed et al., 2010; Al-Waili et al., 2011; Hussein 
et al., 2012). Honey was also known to exert anti-cancer 
effects in several types of cancer cells including colon 
cancer (Jaganathan et al., 2010; Fukuda et al., 2011). 
Malaysian local honey especially Tualang honey has been 
found to induce anti-proliferative effects on cervical and 
breast cancer cell lines (Mohamed et al., 2010) as well 
as anti-bacterial activity against Acinetobacter baumanni 
(Fauzi et al., 2011). Likewise, another local honey, Gelam 
honey has been shown to inhibit the growth of colon 
cancer cell line namely HT 29 (Wen et al., 2012). 
In this study, the anti-proliferative and apoptotic effects 
of ginger, Gelam honey and 5-FU on k-ras mutated cell 
line, HCT 116 were determined. The effects of 5-FU with 
ginger or Gelam honey were then compared to evaluate 
the ability of both compounds to boost the impact of 5-FU 
on growth inhibition and on cellular apoptosis. 
Materials and Methods
Materials
Zingiber officinale (ginger) water extract was kindly 
provided by Noor Azian Morad (Professor, Centre 
for Lipids Engineering Applied Research, Universiti 
Teknologi Malaysia). Briefly, 75g of dried and ground 
ginger were weighed before being loaded into a mesh 
cylinder. The cylinder was then put in a specified reactor 
before 700ml of distilled water was added. N2 gas was 
then allowed into the reactor to remove remaining O2 
gas. Temperature was subsequently set to 140°C while 
the pressure at 35 Bar prior extraction process. Once the 
extraction process is completed, ginger water extract was 
transferred into another reactor where temperature and 
pressure were set to 25°C and 10 Bar respectively to allow 
rapid cooling process to occur. Ginger extracts were then 
collected and subjected for further analysis. Ginger was 
freeze-dried before its use in all experiments. 
Gelam honey was provided by the National Apiary, 
Department of Agriculture, Batu Pahat, Johor, Malaysia. 
The honey was sent to SINAGAMA, Malaysian Nuclear 
Agency for sterilization using the Cobalt-60 source (Model 
JS10000). The irradiation process was done at 25kGy and 
subsequently stored at 4°C for future use. Ginger extract 
and Gelam honey were diluted with complete culture 
medium at varying concentrations for each experiment. 
5-Fluorouracil (5-FU) was purchased from Sigma 
(USA). The drug was prepared as 1M stock solution in 
dimethyl sulfoxide (DMSO) (Sigma, USA) and stored at 
-20°C. For every experiment, 5-FU was diluted with cell 
culture medium to the range of concentration indicated at 
a final DMSO concentration of 0.1% (v/v). All chemicals 
and reagents consumed were of analytical grade. 
Cell culture and treatment
HCT 116 cell line was obtained from the American 
Type Culture Collection (Rockville, USA) and was 
cultured in T-25 flask containing McCoy 5A Medium 
Modified equipped with L-glutamine (Invitrogen, USA) 
supplemented with 10% fetal calf serum (FCS) (PAA 
Laboratories GmbH, Austria), 100U/mL Penicillin-
Streptomycin (Flowlab, Ausralia), and 100U/mL 
Amphotericin B (Flowlab, Australia) at 37°C in a 
humidified atmosphere of 5% CO2. Cells were maintained 
as a monolayer and sub-cultured every 3 days. Cells were 
used when monolayer reached 70% confluence in all 
experiments. 
Cell viability assay
MTS (3 - (4 ,5 -d ime thy l th i azo l -2 -y l ) -5 - (3 -
carboxymethoxyphenyl)-2-(4-sulphenyl)-2H-tetrazolium) 
(Promega, USA) colorimetric assay was used to assess cell 
viability. Briefly, cells were collected via trypsinization and 
separated into single-cell suspensions in complete culture 
medium. Cells were then plated into wells of 96-well plate 
with the density of 25104 cells or 15104 cells (for 5-FU 
experiments) per 100μL complete medium (McCoy 5A 
Medium Modified). Cells were then incubated overnight 
at 37°C in 5% CO2. Culture medium was then removed 
before ginger (1-10mg/mL), Gelam honey (10-110mg/
mL) and 5-Fluorouracil (10-100μM) (Sigma, USA) were 
added either individually or combined. Cells were then 
incubated for another 24h or 72h. After the incubation 
period, culture medium was discarded and replaced with 
MTS solution (Promega, USA) (20μL MTS diluted in 
100μL complete medium) before being incubated again at 
37°C, 5%CO2 for another 2h. The resulting products were 
determined spectrophotometrically at the absorbance of 
490 nm and 405 nm via enzyme-linked immuno-sorbent 
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assay (ELISA) microplate reader (VERSAmax, USA). 
Each experiment was performed in triplicate. 
Combined treatment of ginger and honey on HCT 116 cells
Prior combination of ginger and Gelam honey, 
individual IC50 (the dose at which 50% of maximal 
proliferation was inhibited) was identified from single 
treatment of HCT 116 cells under the conditions specified 
above. To determine the optimal combined inhibitory 
effects, HCT 116 cells were incubated concurrently for 24h 
with fixed concentration of ginger (2mg/mL) and varying 
concentrations of Gelam honey (1-30mg/mL). 
Combination index (CI) analysis
Drugs combination effect was determined by Chou 
-Talalay equation (Chou, 2006), CI=(dA/DA)+(dB/DB), where, 
dA and dB are the doses of individual drugs alone, i.e. 
concentration of 5-FU or ginger/honey respectively that 
gives 50% inhibition. DA and DB are the doses of 5-FU 
and ginger/honey in combination that inhibits 50% of 
cell growth. CI>1, CI=1 and CI<1 indicate antagonistic, 
additive and synergistic effect, respectively
Cell apoptosis measurement by ELISA
Mono- and oligonucleosomes in the cytoplasmic 
fraction were quantified via the Cell Death Detection 
ELISAplus Assay Kit (Roche Diagnostics, Germany) 
according to the manufacturer’s instruction. Briefly, 
HCT 116 cells were initially plated in 96-well plates and 
were allowed to attach overnight. Following overnight 
incubation period, the cells were then treated with 
ginger, Gelam honey and 5-Fluorouracil (individually 
or combined) under the conditions detailed previously. 
After respective incubation periods, HCT 116 treated 
cells were centrifuged and the supernatant retained. 20 
µl aliquots of the supernatant were then added into the 
streptavidin-coated 96 well microliter plates followed 
by 80 µl of immunoreagent, which composed of anti-
histone antibody and anti-DNA-Peroxidase cocktail. 
The plate was incubated for 2h at 37°C before individual 
wells were washed with incubation buffer. 100 µl of 
ABTS solution (substrate peroxidase) was then added 
into respective wells before the amount of nucleosomes 
were spectrophotometrically determined. Absorbance was 
measured at 405 nm via the ELISA microplate reader. The 
results were demonstrated as the ratio of the absorbance 
of treated cells to the control (untreated cells). The 
experiment was conducted in duplicate. 
Statistical analysis
All data are presented as mean±standard deviation 
(SD). Data were analyzed using Repeated Measure – One-
Way Analysis of Variance (ANOVA) followed by Tukey’s 
post-hoc tests, and Repeated Measure - Two-Way ANOVA 
to determine differences between groups. A p value of 
<0.05 was considered statistically significant. 
Results 
Effects of ginger and Gelam honey on HCT 116 cells 
Figure 1A and Figure 1B showed effective growth 
inhibitory effects of ginger and Gelam honey on HCT 116 
cells in a dose dependent manner. Single treatment with 
Gelam honey exhibited a gradual decrease in cell viability 
as the concentration of honey was increased reaching an 
IC50 of 75mg/mL. In contrast, ginger showed much steeper 
decline with regards to its anti-proliferative ability against 
HCT 116 cells reaching an IC50 of 3mg/mL. This indicates 
that ginger is much more potent in inhibiting the growth 
of HCT 116 cells in comparison to Gelam honey.
Effects of combined treatment of ginger extract and gelam 
honey on HCT 116 cells proliferation
In Figure 1C, 2mg/mL of ginger was shown to 
synergistically assist Gelam honey in inhibiting the growth 
of HCT 116 cells reaching an IC50 of less than 30mg/mL 
compared to honey alone (75mg/mL). The Combination 
Indices (CI) determined showed a CI=0.960 (CI<1) 
which demonstrates synergism between the two natural 
compounds. 
Effects of ginger and gelam honey co-treatment with 5-FU 
on HCT 116 cells growth
Figure 1. Growth Inhibitory Effects of Ginger (Zingiber 
officinale) and Gelam Honey on HCT 116 Cells. 
Following an overnight incubation, HCT 116 colon cancer cells 
were then treated with either (A) ginger or (B) Gelam honey at 
varying concentrations and with (C) combination of 2mg/ml 
of ginger and varying dose of Gelam honey.  MTS assay was 
performed after 24h  and percentage of viable cells was measured 
in triplicate (presented as mean±SD, n=3). Statistical analysis 
was performed using Repeated-Measure ANOVA, followed 
by Tukey’s Post-Hoc test. A p value of <0.05 was considered 
statistically significant. ***p<0.001 vs. control
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As illustrated in Figure 2, single and combination 
treatment of 5-FU with either ginger or Gelam honey 
exhibited significant reduction in cell growth as compared 
to the control (untreated) group. 5-FU’s ability to affect 
the growth of HCT 116 cells was further enhanced only 
when the drug was combined with Gelam Honey. The 
combination of a single dose 35mg/mL of Gelam honey 
with 10, 50, 100 µM of 5-FU displayed significant 
suppressive effect on HCT 116 growth in contrast to 5-FU 
alone at the same dosage. The co-treatment effect was 
markedly 3-fold higher resulting in reduced cell growth 
by 72%, 75% and 80% of total growth (as compared to 
5-FU alone). Ginger on the other hand, exhibited different 
readings, as co-treatment of ginger (1.75mg/mL) with 
5-FU (of 10, 50, 100 µM) did not show significant increase 
in the ability of drug to reduce the growth of HCT 116 
cells. The trend was found to be similar to the treatment 
of 5-FU alone. Collectively, these results suggest that 
5-FU treatment reduced the growth of HCT 116 cells, 
but the effect was markedly enhanced when combined 
with Gelam honey. 
Effects of ginger and gelam honey on 5-FU-induced 
stimulation of apoptosis in HCT 116 cells
As shown in Figure 3A, single Gelam honey treatment 
resulted in induction of apoptotic activity (in comparison 
to the control), The value was found to be nearly 5-fold 
higher to that of the control (untreated) samples. However 
there was not much difference in apoptotic activity 
between doses of Gelam honey tested. 
For ginger treatment, a different trend was found as 
illustrated in Figure 3B. 3mg/mL of ginger was found 
to induce the highest apoptotic activity by 4-fold in 
comparison to that of the control and 2mg/mL treated 
samples. The increased apoptotic activity was significant 
when compared to the control (p<0.05). 
However, with regards to the combined treatment of 
the two natural compounds, only a moderate increase of 
apoptotic activity was observed in treated samples (Figure 
Figure 4. Effects of 5-Fluorouracil Alone and in 
Combination with Ginger or Gelam Honey on the 
Induction of Apoptosis in HCT 116 Cells. Cells were 
treated with 5-Fluorouracil alone at 10 μM, 50 μM, and 100 
μM or co-treated with fixed concentration of ginger or Gelam 
honey (at the same dosage). After 72h, nucleosomes from drug-
treated cells were then measured using the Cell Death Detection 
ELISAplus Assay Kit as described in Figure 3. Statistical 
analysis was performed using Repeated-Measure Two-way 
ANOVA, followed by Bonferroni post-tests. A p value of <0.05 
was considered statistically significant. *p<0.05, **p<0.01 vs. 
5-FU
Figure 2. Growth Inhibitory Effects of 5-Fluorouracil 
Alone and in Combination with Ginger or Gelam 
Honey on HCT 116 Cells. After an overnight incubation cells 
were treated with 5-Fluorouracil at (10μM, 50μM, and 100 μM) 
and in combination with fixed concentration of ginger or Gelam 
honey and MTS assay was performed after 72h. Percentage 
of viable cells gained from individual and co-treatment of the 
drug was measured in triplicate (presented as mean±SD, n=3). 
Statistical analysis was performed using Repeated-Measure 
Two-way ANOVA, followed by Bonferroni post-tests. A p value 
of <0.05 was considered statistically significant. **p<0.01, 
***p<0.001 vs. 5-FU
Figure 3. Induction of Apoptosis of HCT 116 Cells 
by Ginger and Gelam Honey. Cells were treated with (A) 
Gelam honey, (B) ginger, and (C) combination of both (2mg/
mL of Ginger combined with varying concentrations of Gelam 
honey). After 24 h, nucleosomes in the cytoplasmic fraction 
from treated cells were quantified via the Cell Death Detection 
ELISAplus Assay Kit. Apoptotic activity was expressed as 
enrichment factor [the ratio of the absorbance value of treated 
cells to the Control (untreated cells)]. Experiments were done 
in duplicates (presented as mean±SD, n=1). Statistical analysis 
was performed using Repeated-Measure ANOVA, followed 
by Tukey’s Post-Hoc test. A p value of <0.05 was considered 
statistically significant. *p<0.05, **p<0.01 vs. control
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3C). The combination dose of 32mg/mL of Gelam honey 
with 2mg/mL of ginger induced significantly higher 
apoptotic activity in HCT 116 treated cells. 
While single and combination treatment of ginger and 
Gelam honey increased the apoptotic activity, surprisingly 
single 5-FU treatment (10, 50, 100 µM) produced in 
significant changes in apoptotic activity post-treatment 
(when compared to control). However, combinations of 
5-FU treatment with either natural compound, particularly 
ginger extract caused significant changes in the apoptotic 
activity (Figure 4). Apoptotic activity of 5-FU combined 
with 1.75mg/mL ginger significantly increased for all dose 
combination post-treatment. While this is true for ginger, 
co-treatment of the drug (at 50 and 100 µM) with 35mg/
mL of Gelam honey surprisingly resulted in significant 
decrease of apoptotic activity. 
Discussion
Combination therapy in the approach of killing 
cancer cells have been a major focus in the formulation 
of effective concoction of chemotherapeutic drugs such 
as 5-FU in combination with oxaliplatin in the treatment 
of colon cancer. Due to concern on minimizing the 
adverse side effects from these drugs, concoction of 
natural products that are often present in our dietary 
food regime such as ginger and honey could be potential 
chemopreventive agents against colon adenocarcinoma 
since they are considered as safe food (Zhu et al., 2013). 
Consumptions of foods rich in phytochemical antioxidants 
has been shown to have chemopreventive effect against 
many types of cancers (Aggarwal et al., 2004). In this 
present study, crude ginger (Zingiber officinale) extract 
and Gelam honey were tested in combination doses 
in inhibiting growth of colon cancer cells HCT 116. 
Inhibiting cell proliferation and inducing apoptosis in 
cancer cells are effective strategies for combating tumor 
(Manju and Nalini, 2005). 
Our data indicate a dosage of about 3 mg/mL ginger 
extract is sufficient to inhibit 50% growth (IC50) of HCT 
116 colon cancer cells. It is quite interesting to note that 
the same dose of ginger extract is required for inducing 
highest apoptotic activity in the cancer cells (Figures 1A 
and 3B), This could suggest that 3mg/ml is a very effective 
dose of ginger extract for optimized anti-cancer effect on 
colon adenocarcinoma. Other studies have also reported 
the anti proliferative property of ginger extract in colon 
cancer cells lines HCT 15 and HT 29 (Kim et al., 2008; Lee 
et al., 2008; Yogosawa et al., 2012). We have previously 
demonstrated that ginger extract inhibited the growth 
of HepG2 hepatoma cells and the formation of tumor 
in liver cancer-induced rats (Mohd Yusof et al., 2008). 
Ginger was believed to suppress the hepatocarcinogenesis 
mainly through induction of apoptosis in the cancer 
cell, as indicated by downregulation of anti-apoptotic 
Bcl-2 protein and upregulation of pro-apoptotic protein 
caspase-8 (Mohd Yusof et al., 2008), as well as supressing 
inflammation (Jeong et al., 2009; Sang et al., 2009) by 
inactivating nuclear factor-kappa beta (NF-κβ) (Habib et 
al., 2008). Other studies have also reported the mechanism 
of anti-tumour effect of ginger extract via induction of 
apoptosis in various human cancer cell lines following 
treatment with ginger phenolic compounds (Lee and Surh, 
1998; Miyoshi et al., 2003). 
Two major pharmacological active components found 
in ginger are 6-gingerol and 6-shogaol. However, shogaols 
have gained more interest because of recent discoveries 
revealing their higher anti-cancer potencies over gingerols 
(Sang et al., 2009). Another component in ginger extract, 
zerumbone, a sesquiterpene in ginger, has been suggested 
to induce apoptosis in HCT 116 cell line as indicated by 
upregulation of tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL) death receptor (DR) 4 and 
DR5 (Yodkeeree et al., 2009) while 6-shogaol has been 
suggested to induce apoptosis in colon adenocarcinoma 
cell line COLO 205 (Pan et al., 2008). Nevertheless in 
this study crude ginger extract was used instead of either 
individual gingerol or shogaol as there is recent evidence 
suggesting combination of active compounds present in 
ginger could synergistically enhance the anti-cancer effect 
of ginger (Brahmbhatt et al., 2013). 
Honey is also thought to exhibit its anti-cancer 
property through several mechanisms. Promoting 
apoptosis and suppressing cell proliferation are examples 
of mechanism by which honey could exhibit its anti-cancer 
property (Jaganathan and Mandal, 2010; Jaganathan et 
al., 2011; Jaganathan, 2012; Ahmed and Othman, 2013). 
Despite accumulating evidence suggesting the potential 
of honeys in combating colorectal cancer, there is not 
much evidence regarding local Gelam honey having anti-
cancer effect and especially colon cancer in particular. 
There might be differences in the anti-cancer property 
attributed to differences in the composition of biochemical 
constituents between different types of honeys (Gheldof et 
al., 2002; Khalil et al., 2011; Chua et al., 2013). The work 
documented here is an extension to our previous work in 
colon adenocarcinoma cell line HT 29 where, we found 
that Gelam honey exhibited higher chemopreventative 
effects on HT 29 colon cancer cell line than Nenas honey 
by inducing apopotosis and suppressing inflammation 
possibly through its antioxidant property (Wen et al., 
2012). These two types of Malaysian honeys have 
been reported earlier having their antioxidant activities 
significantly correlated to the content of the phenolic 
compounds (Hussein et al., 2011).
To our knowledge, this study is the first to demonstrate 
the anti cancer potential of Gelam honey by inhibiting the 
proliferation and inducing apoptosis of HCT 116 colon 
cancer cells. The most possible mechanism of anti-cancer 
effect of Gelam honey is by arresting cancer cells at G0/G1 
phase and inducing pro apoptotic proteins as demonstrated 
in colon cancer HCT 15 and HT 29 cells by Jaganathan 
and Mandal (2009, 2010). A previous study has suggested 
that chrysin, a flavanoid component found in honey, is 
responsible for the anti-cancer property against HCT 116 
cells by promoting tumor necrosis factor (TNF)-related 
apoptosis-inducing ligand (TRAIL)-induced apoptosis 
(Li et al., 2011). Another phenolic component of honey, 
p-Coumaric acid has been shown to induce apoptosis in 
colon adenocarcinoma cell line HCT 15 (Jaganathan et 
al., 2013).
Combinations of active compounds from plant extracts 
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are becoming a new strategy in anti-cancer treatments. 
Majumdar et al. (2009) have reported the combination 
of curcumin and resveraterol was effective in inhibiting 
the growth of colon cancer cells. In the present study, we 
found that treatment on HCT 116 colon cancer cells with 
ginger extract and Gelam honey displayed synergism in 
inhibiting its proliferation as indicated from the CI analysis 
<1. Treatment with 2mg/ml of ginger reduced the IC50 
dose of Gelam honey required for inhibiting the growth 
of 50% of HCT 116 cells to about one-third (Figures 1B 
and 1C). However, there was no synergism between ginger 
extract and Gelam honey in inducing apoptosis of HCT 
116 cells (Figure 3). 
5-FU, a chemotherapy drug used in the treatment of 
many cancer types, was shown in earlier studies to interact 
synergistically with either triptolide or dichloroacetate in 
killing HT29 cells (Tang et al., 2007; Tong et al., 2011). 
Combination treatment of 5-FU with dichloroacetate 
enhanced the 5-FU cytotoxicity and hence reduced the 
effective drug dose from 798.4µM to 80.0µM (Tang et 
al., 2007). It was quite interesting to note in our study 
that the combination of 5-FU with Gelam honey was able 
to further enhance the capability of 5-FU in suppressing 
growth of HCT 116 cells. However, we did not notice 
the same enhancing effect when 5-FU was combined 
with ginger. On the contrary, ginger extract was able to 
enchance the apoptosis effect of 5-FU. A study by Ng et 
al. (2014) showed the enchancement of cytotoxicity of 
5FU against colon cancer HT29 cells when treated with 
Piper betle leaf extract. 
In summary, our study demonstrates that ginger 
extract and Gelam honey inhibit proliferation as well as 
induce apoptosis of a colon adenocarcinoma cell line, 
HCT 116 in vitro. Moreover they displayed synergism 
in anti-proliferative activity against colon cancer cells 
when combined. Co-treatment with either ginger extract 
or Gelam honey also enhanced the anti-tumor effect of 
5-FU on the cancer cell line as indicated by increased rate 
of apoptosis and inhibition of cell growth as compared to 
treatment with the anti-cancer agent alone. 
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